Genomics BioSci & Tech. Co.,Ltd. (4195.TWO)
TWD 16.15
(-9.01%)
TWD 16.15
(-9.01%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1.13 Billion TWD | 1.26% |
| 2022 | 1.11 Billion TWD | 31.24% |
| 2021 | 853.18 Million TWD | -26.15% |
| 2020 | 1.15 Billion TWD | 26.35% |
| 2019 | 914.3 Million TWD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 1.27 Billion TWD | 0.0% |
| 2024 Q1 | 1.27 Billion TWD | 12.78% |
| 2023 FY | 1.13 Billion TWD | 1.26% |
| 2023 Q3 | 1.13 Billion TWD | 0.64% |
| 2023 Q2 | 1.12 Billion TWD | 0.0% |
| 2023 Q4 | 1.13 Billion TWD | 0.0% |
| 2023 Q1 | 1.12 Billion TWD | 0.62% |
| 2022 Q3 | 1.11 Billion TWD | 0.0% |
| 2022 Q4 | 1.11 Billion TWD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | 128.04 Million TWD | -785.49% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 2.9 Billion TWD | 60.914% |
| Level Biotechnology Inc. | 822.67 Million TWD | -37.824% |
| Sagittarius Life Science Corp | 664.72 Million TWD | -70.574% |
| NeoCore Technology Co., Ltd. | 548.74 Million TWD | -106.624% |
| TaiMed Biologics Inc. | 3.89 Billion TWD | 70.882% |
| GlycoNex Incorporation | 1.55 Billion TWD | 26.981% |
| VBI | 452.1 Million TWD | -150.794% |
| GeneReach Biotechnology Corp. | 1.17 Billion TWD | 3.596% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 748.57 Million TWD | -51.468% |
| SynCore Biotechnology Co.,Ltd | 378.36 Million TWD | -199.672% |
| Visgeneer Inc. | 397.17 Million TWD | -185.476% |
| Mycenax Biotech Inc. | 3.77 Billion TWD | 69.928% |
| Sunmax Biotechnology Co., Ltd. | 2.15 Billion TWD | 47.484% |
| G&E Herbal Biotechnology Co., Ltd. | 883.09 Million TWD | -28.394% |
| Neith Corporation | 192.15 Million TWD | -490.074% |
| Medigen Vaccine Biologics Corporation | 6.09 Billion TWD | 81.39% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 73.55 Million TWD | -1441.429% |
| Enimmune corporation | 604.82 Million TWD | -87.466% |
| TaiRx, Inc. | 833.74 Million TWD | -35.994% |
| CHO Pharma, Inc. | 3.08 Billion TWD | 63.259% |
| EirGenix Inc. | 11.16 Billion TWD | 89.842% |
| BioLASCO Taiwan Co., Ltd. | 573.13 Million TWD | -97.831% |
| Sunny Pharmtech Inc. | 1.71 Billion TWD | 33.785% |
| Lin BioScience, Inc. | 3.59 Billion TWD | 68.476% |
| BioGend Therapeutics Co., Ltd. | 1.05 Billion TWD | -7.936% |
| Feng Chi Biotech Corp. | 301.03 Million TWD | -276.652% |
| Bio Preventive Medicine Corp. | 264.65 Million TWD | -328.42% |
| Lukas Biomedical Inc. | 441.19 Million TWD | -156.996% |
| RBC Bioscience Corporation | 753.79 Million TWD | -50.419% |
| BiOptic Inc. | 613.77 Million TWD | -84.733% |
| BRIM Biotechnology, Inc. | 1.77 Billion TWD | 36.253% |
| Shine-On BioMedical Co.,Ltd. | 1.15 Billion TWD | 2.231% |
| Great Novel Therapeutics Biotech & Medicals | 644.84 Million TWD | -75.831% |
| Syngen Biotech Co.,Ltd. | 3.1 Billion TWD | 63.498% |
| Advagene Biopharma Co., Ltd. | 147.93 Million TWD | -666.453% |
| NaviFUS Corp. | 490.53 Million TWD | -131.144% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 1.22 Billion TWD | 7.495% |
| Sinew Pharma Inc. | 1.36 Billion TWD | 16.836% |
| Andros Pharmaceuticals Co.,Ltd | 529.14 Million TWD | -114.278% |
| Greenyn Biotechnology Co., Ltd | 1.16 Billion TWD | 2.372% |
| Lumosa Therapeutics Co., Ltd. | 1.65 Billion TWD | 31.543% |
| AP Biosciences Inc | 890.75 Million TWD | -27.29% |
| Medigen Biotechnology Corp. | 8.52 Billion TWD | 86.703% |
| 3D Global Biotech Inc. | 324.14 Million TWD | -249.792% |
| Pharmosa Biopharm Inc. | 1.33 Billion TWD | 14.981% |
| Intech Biopharm Corporation | 2.71 Billion TWD | 58.177% |
| Oneness Biotech Co., Ltd. | 15.36 Billion TWD | 92.62% |
| Eusol Biotech Co.,Ltd. | 410.25 Million TWD | -176.373% |
| TWi Biotechnology, Inc. | 396.85 Million TWD | -185.71% |
| Ever Supreme Bio Technology Co., Ltd | 2.07 Billion TWD | 45.381% |
| TCI GENE Inc. | 1.16 Billion TWD | 2.753% |
| MegaPro Biomedical Co., Ltd | 294.58 Million TWD | -284.901% |
| Senhwa Biosciences, Inc. | 1.36 Billion TWD | 16.833% |
| Taiwan Bio Therapeutics Co., Ltd | 941.76 Million TWD | -20.396% |
| NatureWise Biotech & Medicals Corporation | 698.45 Million TWD | -62.337% |
| PharmaEngine, Inc. | 3.95 Billion TWD | 71.324% |
| Savior Lifetec Corporation | 3.82 Billion TWD | 70.339% |
| TaiGen Biopharmaceuticals Holdings Limited | 1.22 Billion TWD | 7.805% |
| OBI Pharma, Inc. | 5.6 Billion TWD | 79.767% |
| Meribank Biotech Co., Ltd | 1.06 Billion TWD | -6.764% |
| Acepodia, Inc. | 6.81 Billion TWD | 83.371% |
| Caliway Biopharmaceuticals Co., Ltd. | 3.82 Billion TWD | 70.369% |